NCT06011460Enrolling by invitation
Observation of Clozapine Treatment Safety in Bipolar Disorder.
Source: ClinicalTrials.gov · Last updated 25 Aug 2023 · Not updated for over 12 months - ask the site whether it is still open
Brief summary (registry, in English)
The purpose of the registry is to record incidence of adverse events during treatment with clozapine in patients suffering from bipolar disorder.
- Status (registry)
- Enrolling by invitation
- Study type
- Observational
- Enrollment
- 30 (estimated)
- First submitted
- 21 Aug 2023
- Start date
- 23 Feb 2023
- Primary completion date
- 31 Dec 2024
- Lead sponsor
- Medical University of Gdansk
- Diseases
- Bipolar disorder
- NCT number
- NCT06011460
What you commit to
- Study type: Observational
- Planned participants: 30
- From 23 Feb 2023 to the primary completion date, 31 Dec 2024
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other
- Patients unable to give fully written informed consent
- Patients unable to comply with the requirements
Who the study is looking for
- Diagnosis of treatment-resistant depressive episode in the course of bipolar disorder according to DSM-5.
- Age from 18 to 65 years old.
Age in the registry: 18 years to 65 years · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Department of Psychiatry, Medical University of Gdańsk Coordinator of this site? Confirm its status | Gdansk | Poland | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.